Should the Hepatitis C Positive End Stage Renal Disease Patient Be Transplanted?
1996; Wiley; Volume: 9; Issue: 1 Linguagem: Inglês
10.1111/j.1525-139x.1996.tb00889.x
ISSN1525-139X
AutoresDaniel Glicklich, Toros Kapoian,
Tópico(s)Liver Disease and Transplantation
ResumoSeminars in DialysisVolume 9, Issue 1 p. 5-8 Should the Hepatitis C Positive End Stage Renal Disease Patient Be Transplanted? Daniel Glicklich, Corresponding Author Daniel Glicklich Division of Nephrology, Department of Medicine, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, New YorkRenal Division, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467. Seminars in Dialysis–Vol 9, No 1 (Jan-Feb) 1996 pp 5–8Search for more papers by this authorToros Kapoian, Toros Kapoian Division of Nephrology, Department of Medicine, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, New YorkSearch for more papers by this author Daniel Glicklich, Corresponding Author Daniel Glicklich Division of Nephrology, Department of Medicine, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, New YorkRenal Division, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467. Seminars in Dialysis–Vol 9, No 1 (Jan-Feb) 1996 pp 5–8Search for more papers by this authorToros Kapoian, Toros Kapoian Division of Nephrology, Department of Medicine, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, New YorkSearch for more papers by this author First published: January 1996 https://doi.org/10.1111/j.1525-139X.1996.tb00889.xCitations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Kirkman RL, Strom TB, Weir MR, Tilney NRL: Late mortality and morbidity in recipients of long-term renal allografts. Transplantation 34: 347–351, 1982. 10.1097/00007890-198212000-00007 PubMedWeb of Science®Google Scholar 2 Lefroncois N., Elmghabbar N., Chossegros P., Beutel H., Faure JL, Revillard JP, Traeger J., Duberhard JM, Torraine JL: Long term results in kidney transplantation: Patient and graft survival, causes of graft failure and mortality, renal function and complications after ten years. Transpl Proc 19: 3767–3768, 1987. Google Scholar 3 Rao KV, Anderson RC: Long-term results and complication in renal transplant recipients: observations in the second decade. Transplantation 45: 45–52, 1988. 10.1097/00007890-198801000-00011 CASPubMedWeb of Science®Google Scholar 4 Sengar DPS, Couture RA, Lazarovits AI: Long-term patient and renal allograft survival in HBsAg infection. Transpl Proc 21: 3358–3359, 1989. PubMedWeb of Science®Google Scholar 5 First MR: Long-term complications after transplantation. Am J Kidney Dis 22: 477–486, 1993. 10.1016/S0272-6386(12)70156-7 CASPubMedWeb of Science®Google Scholar 6 Caramelo C., Ortiz A., Aguilera B., Porres JC, Navas S., Marriott E., Alberola ML, Alamo C., Galera A., Garron MP, Gonzalez-Parra E., Fernandez de Gabriel MV, Oliva H., Carreno V.: Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis 22: 822–828, 1993. 10.1016/S0272-6386(12)70341-4 PubMedWeb of Science®Google Scholar 7 Pol S., Romeo R., Zins B., Driss F., Lebkin B., Carnot F.: Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int 44: 1097–1100, 1993. 10.1038/ki.1993.354 PubMedWeb of Science®Google Scholar 8 Kuhns M., de Medina M., McNamara A., Jeffers LJ, Reddy KR, Silva M., Ortiz L., Jiminez M., Schiff ER: Detection of hepatitis C virus RNA in hemodialysis patients. J Am Soc Nephrol 4: 1491–1497, 1994. CASPubMedWeb of Science®Google Scholar 9 Simon N., Courouce AM, Lemarreo N., Trepo C., Ducamp S.: A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 46: 504–511, 1994. 10.1038/ki.1994.301 CASPubMedWeb of Science®Google Scholar 10 Roth D.: Hepatitis C virus: The nephrologist's view. Am J Kidney Dis 25: 3–16, 1995. 10.1016/0272-6386(95)90617-7 PubMedWeb of Science®Google Scholar 11 Natov SN, Pereira BJG: Hepatitis C infection in patients on dialysis. Sem Dialysis 7: 360–368, 1994. 10.1111/j.1525-139X.1994.tb00855.x Web of Science®Google Scholar 12 Pereira BJG, Milford EL, Kirkman RL, Sayre KR, Johnson PJ, Wilber JL, Quan S., Levey AS: Prevalence of HCV RNA in hepatitis antibody positive cadaveric organ donors and their recipients. N Engl J Med 327: 910–915, 1992. 10.1056/NEJM199209243271302 PubMedWeb of Science®Google Scholar 13 Bukh J., Wantzin P., Krogsgaard K., Knudsen F., Purcell RH, Miller RH: High prevalence of hepatitis C virus RNA in dialysis patients: Significant number of patients with HCV infection. J Infect Dis 168: 1343–1348, 1993. 10.1093/infdis/168.6.1343 PubMedWeb of Science®Google Scholar 14 Chan T., Lok ASF, Chen IKP, Chan RT: A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 104: 862–868, 1993. 10.1016/0016-5085(93)91023-B PubMedWeb of Science®Google Scholar 15 Alter MI, Margolis HS, Krawczynski K., Judson FN, Mares A., Alexander WJ, Hu Py, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ: The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327: 1899–1905, 1992. 10.1056/NEJM199212313272702 CASPubMedWeb of Science®Google Scholar 16 Goffin E., Pirson Y., Cornu C., Gerbel A., Squifflet JP, Van Ypersele de Strihou C.: Outcome of HCV infection after renal transplantation. Kidney Int 45: 551–555, 1994. 10.1038/ki.1994.71 CASPubMedWeb of Science®Google Scholar 17 Meshari KA, Shaibani KA, Alfurayh O., Qunibi WY, Ali MA: Kidney Transplantation in HCV infected hemodialysis patients with mild hepatitis: a prospective controlled study of liver disease and graft function. J Am Soc Nephrol 5: 993, 1994. Google Scholar 18 Strauss RM, Gitlin N., Caudill M., Neylan IF, Nolte FS, Whelchel JD, Boyer TD: Chronic hepatitis C: A contraindication to renal transplantation? Hepatology 18: 344A, 1993. 10.1016/0270-9139(93)92900-K Web of Science®Google Scholar 19 Roth D., Zucker K., Cirocco R., DeMattos A., Burke GW, Nery J., Esquenazi V., Babischkin S., Miller J.: The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 45: 238–244, 1994. 10.1038/ki.1994.29 CASPubMedWeb of Science®Google Scholar 20 Dubois DB, Gretch D., del Rosa C., Lee W., Fine J., Blagg CR, Corey L.: Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: Gender-related differences in viral load. Am J Kidney Dis 24: 795–801, 1994. 10.1016/S0272-6386(12)80673-1 PubMedWeb of Science®Google Scholar 21 Glicklich D., Reinus I., Greenstein S., Scheduler R., Mallis M., Clem-etson S., Tellis V.: Hepatitis C infection in renal transplant recipients: Histology and clinical features. J Am Soc Nephrol 5: 1007, 1994. Google Scholar 22 Kiyosawa K., Sodeyama T., Tanaka E., Gibo Y., Yoshikawa K., Nakano Y., Furuta S., Akahane Y., Nishioka K., Purcell RH, Alter HJ: Interrelations of blood transfusion, non-A non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12: 671–675, 1990. 10.1002/hep.1840120409 CASPubMedWeb of Science®Google Scholar 23 Tong MJ, El-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated Hepatitis C. N Engl J Med 332: 1463–1466, 1995. 10.1056/NEJM199506013322202 CASPubMedWeb of Science®Google Scholar 24 Stempel CA, Lake J., Kuo G., Vincenti F.: Hepatitis C–its prevalence in end-stage renal failure patients and clinical course after kidney-transplantation. Transplantation 55: 273–276, 1993. 10.1097/00007890-199302000-00008 CASPubMedWeb of Science®Google Scholar 25 Pol S., Legendre C., Saltiel C., Carnot F., Brechot C., Berthelot P., Mattlinger B., Kreis H.: Hepatitis C virus in kidney recipients: Epidemiology and impact on renal transplantation. J Hepatol 15: 202–206, 1992. 10.1016/0168-8278(92)90036-O CASPubMedWeb of Science®Google Scholar 26 Pol S., Hepatitis C virus infection in hemodialyzed patients and kidney allograft recipients. Advances in Nephrology 24: 315–330, 1995. CASPubMedGoogle Scholar 27 Pereira BJG, Milford EL, Kirkman RL, Levey AS: Transmission of hepatitis c virus by organ transplantation. N Engl J Med 325: 454–460, 1991. 10.1056/NEJM199108153250702 CASPubMedWeb of Science®Google Scholar 28 Alfurayh O., Sobh M., Buali AR, Ali MA, Barri Y., Qunibi W., Taher S.: Hepatitis C infection in chronic hemodialysis patients, a clinicopathologic study. Nephrol Dial Transplant 7: 327–332, 1992. 10.1093/oxfordjournals.ndt.a092137 PubMedWeb of Science®Google Scholar 29 Casanovas-Taltavull T., Baliellas C., Fernandez-Esparrach G., Rota R., Casas R., Benasco C., Grino JM, Andres E., Casais L., Liver biopsy in hemodialysis patients with chronic hepatitis C virus infection: A prospective study to determine the impact of liver injury severity on patients outcome. Hepatology 18: 326A, 1993. 10.1016/0270-9139(93)92829-O Web of Science®Google Scholar 30 Nieto J., Ferreras I., Mora F., Caparros G., Sanchez A., de la Torre M., Peces R.: Liver histopathological findings in hemodialysis patients with chronic hepatitis C virus infection. Nephrol Dial Transplant 8: 971, 1993. Google Scholar 31 Ozyilkan E., Akpolat T., Arik N., Koseoglo HT, Telatar H.: Characteristics of chronic hepatitis C virus infection in patients on maintenance hemodialysis. Nephrol Dial Transplant 9: 1697–1698 1994. CASPubMedWeb of Science®Google Scholar 32 Morales IM, Dominques P., Colina F., Lopez Carreira M., Castellano G., Fuertes A., Andres A., Fernandez G., Rodicio IL: Peculiarity of histological liver disease in hepatitis C infected kidney transplanted patients. J Am Soc Nephrol 5: 1025, 1994. Google Scholar 33 Morales IM, Munoz MA, Castellano G., Colina F., Fuertes A., Andres A., Campo C., Blasco A., Hernandez E., Rodicio IL: Impact of hepatitis C in long-functioning renal transplants–a clinicopathological follow up. Transplant Proc 25: 1450–1453, 1993. CASPubMedWeb of Science®Google Scholar 34 Chan TM, Wu PC, Lau JYN, Lai CL, Lok ASF, Cheng IKP: Clini-copathologic features of hepatitis C virus infection in renal allograft recipients. Transplantation 58: 996–1000, 1994. 10.1097/00007890-199411150-00004 CASPubMedWeb of Science®Google Scholar 35 Rao KV, Anderson WR, Kasiske BL: Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 94: 241–250, 1993. 10.1016/0002-9343(93)90055-T CASPubMedWeb of Science®Google Scholar 36 Simmonds P.: Variability of Hepatitis C virus. Hepatology 21: 570–583, 1995. 10.1002/hep.1840210243 CASPubMedWeb of Science®Google Scholar 37 Davis GL, Balart LA, Schiff ER, Lindsay K., Bodenheimer HC, Perrillo RP, Carey W., Jacobson IM, Payne J., Dienstag IL, Van Thiel DH, Tamburro C., Lefkowitch I., Albrecht I., Meschievitz C., Ortego TI, Gibas A.: Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized controlled trial. N Engl J Med 321: 1501–1506, 1989. 10.1056/NEJM198911303212203 PubMedGoogle Scholar 38 Ohnishi K., Nomura F., Nakano M.: Interferon therapy for acute posttransfusion non-A, non-B hepatitis: Response with respect to anti-hepatitis C virus antibody status. Am J Gastroenterol 86: 1041–1049, 1991. PubMedWeb of Science®Google Scholar 39 Koenig P., Vogel W., UmLauft F., Weyrer K., Prommeggar R., Lhotta K., Neyer N., Stumavoll HK, Grunewald K.: Interferon treatment for chronic hepatitis C virus infection in uremic patients. Kidney Int 45: 1507–1509, 1994. 10.1038/ki.1994.197 PubMedWeb of Science®Google Scholar 40 Rao VK, Anderson WR: Effectiveness of alpha interferon treatment in altering the clinical and histological course of chronic viral hepatitis of ESRD patients awaiting renal transplantation. J Am Soc Nephrol 5: 1032, 1994. Web of Science®Google Scholar 41 Cerini R., Cozzolino G., Morante R., Lucariello A., De Rosa ML, Cacciatore F.: Relatively high dose for twelve months recombinant leukocyte interferon-alpha treatment in chronic hepatitis: A randomized controlled study. Hepatology 14: 70A, 1991. Web of Science®Google Scholar 42 Kovarik J., Mayer G., Pohanka E., Schwartz M., Traindl O., Graf H., Smolen I.: Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Transplantation 45: 402–405, 1988. 10.1097/00007890-198802000-00031 PubMedWeb of Science®Google Scholar 43 Kramer P., Ten Kate FWI, Bijnen AB, Jeekel J., Weimer W.: Recombinant leukocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet 1: 989–990, 1984. 10.1016/S0140-6736(84)92327-4 CASPubMedWeb of Science®Google Scholar 44 Rostaing L., Baron E., Modesto A., Girolami JP, Durand D., Sue JM: Renal failure in renal transplant patients treated with interferon A for chronic hepatitis C. J Am Soc Nephrol 5: 1034, 1994. Google Scholar 45 Rhodes J., Jones DH, Bleeher NM: Increased expression of human monocyte HLA-DR antigens and Fc receptors in response to human interferon in vivo. Clin Exp Immunol 53: 739–744, 1983. CASPubMedWeb of Science®Google Scholar Citing Literature Volume9, Issue1January 1996Pages 5-8 ReferencesRelatedInformation
Referência(s)